Evolus (EOLS) Cash from Investing Activities Growth (1y) (2019 - 2026)
Evolus (EOLS) Cash from Investing Activities Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 13.93% |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 57.14% |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 551.55% |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | -3,664.79% |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | -3.45% |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | -22,919.16% |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 140.78% |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 52.90% |
| 10 | Evolus | 439.03 Mn | 389.24 Mn | 48.90 Mn | 9.13% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.13% |
| Dec 31, 2025 | -59.03% |
| Sep 30, 2025 | -53.05% |
| Jun 30, 2025 | -80.78% |
| Mar 31, 2025 | -133.50% |
| Dec 31, 2024 | -277.29% |
| Sep 30, 2024 | -161.60% |
| Jun 30, 2024 | -480.56% |
| Mar 31, 2024 | -55.97% |
| Dec 31, 2023 | 74.05% |
| Sep 30, 2023 | 40.04% |
| Jun 30, 2023 | 44.33% |
| Mar 31, 2023 | -95.79% |
| Dec 31, 2022 | -256.67% |
| Sep 30, 2022 | -4,380.95% |
| Jun 30, 2022 | -0.52% |
| Mar 31, 2022 | -105.45% |
| Dec 31, 2021 | -101.98% |
| Sep 30, 2021 | -99.93% |
| Jun 30, 2021 | -104.12% |